Wacker Chemie AG (WCHD.XC)
- Previous Close
64.43 - Open
64.43 - Bid 67.30 x --
- Ask 66.80 x --
- Day's Range
64.43 - 64.43 - 52 Week Range
64.43 - 104.00 - Volume
164 - Avg. Volume
85 - Market Cap (intraday)
3.204B - Beta (5Y Monthly) 1.04
- PE Ratio (TTM)
13.28 - EPS (TTM)
4.85 - Earnings Date Jul 31, 2025
- Forward Dividend & Yield 2.50 (3.88%)
- Ex-Dividend Date May 8, 2025
- 1y Target Est
--
Wacker Chemie AG, together with its subsidiaries, provides chemical products worldwide. It operates through four divisions: Silicones, Polymers, Biosolutions, and Polysilicon. The Silicones division offers silanes, siloxanes, silicone fluids, silicone emulsions, silicone elastomers, silicone resins, and pyrogenic silica. The Polymers division provides binders and polymeric additives, such as dispersible polymer powder and dispersions, which are used in construction, paper, paint, coating, and adhesive industries. The Biosolutions division offers customized biotech and catalog products for fine chemicals, such as pharmaceutical proteins, vaccines, cyclodextrins, cysteine, polyvinyl acetate solid resins, and acetylacetone for pharmaceutical actives, food additives, and agrochemicals. The Polysilicon division produces hyperpure polysilicon for use in semiconductor and solar sectors. Wacker Chemie AG was founded in 1914 and is headquartered in Munich, Germany. Wacker Chemie AG is a subsidiary of Dr. Alexander Wacker Familiengesellschaft mbH.
www.wacker.com16,655
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: WCHD.XC
View MorePerformance Overview: WCHD.XC
Trailing total returns as of 5/23/2025, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: WCHD.XC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: WCHD.XC
View MoreValuation Measures
Market Cap
3.08B
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.56
Price/Book (mrq)
0.69
Enterprise Value/Revenue
0.66
Enterprise Value/EBITDA
4.63
Financial Highlights
Profitability and Income Statement
Profit Margin
3.31%
Return on Assets (ttm)
1.29%
Return on Equity (ttm)
4.40%
Revenue (ttm)
5.71B
Net Income Avi to Common (ttm)
188.9M
Diluted EPS (ttm)
4.85
Balance Sheet and Cash Flow
Total Cash (mrq)
898.3M
Total Debt/Equity (mrq)
37.68%
Levered Free Cash Flow (ttm)
-411.71M